Pretreatment of GBM cells with AICA or the AMPK activator A769662 reduced TMZ-induced cell apoptosis (Supplementary Fig. 4a, b) with shortened γ-H2AX dynamics (Fig. 4a, b), reflecting the protective effects of AICA and AMPK activation. The gene discussed is PRKAA1; the disease is glioblastoma.